J&J Will Maintain Rx Headcount Through 2004 Under Cost-Cutting Plan
Executive Summary
Johnson & Johnson expects its pharmaceutical employee headcount to remain constant in 2004
You may also be interested in...
J&J Headcount Reduction Program On Target; Company Posts Strong Quarter
Johnson & Johnson's headcount reduction program is on target, with 1,000 employees taking advantage of an early retirement option, CFO Robert Darretta said on an April 13 conference call
J&J Headcount Reduction Program On Target; Company Posts Strong Quarter
Johnson & Johnson's headcount reduction program is on target, with 1,000 employees taking advantage of an early retirement option, CFO Robert Darretta said on an April 13 conference call
J&J Focusing On “Product Solutions”; Diabetes Care May Be Early Model
Johnson & Johnson is moving towards a business model focused on offering "product solutions" for the health care system, Biopharmaceuticals Group Chairman Joseph Scodari told the Wharton Health Care Business Conference Feb. 19 in Philadelphia